Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × 177Lu-octreotide, DOTA(0)-Tyr(3)- × Clear all

Phase

Phase 3 4 Phase 2 4 Phase NA 1 Phase EARLY_PHASE1 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Exercise 376 Blood Specimen Collection 308 Standard of Care 282 Magnetic Resonance Spectroscopy 242 Radiotherapy 231 Surveys and Questionnaires 218 Radiosurgery 216 Educational Status 207 Methods 203 Early Intervention, Educational 193 Practice Guidelines as Topic 136 Biopsy 130 Interviews as Topic 129 Drug Therapy 122 Surgical Procedures, Operative 118 Control Groups 118 Acupuncture Therapy 114 Therapeutics 95 Cyclophosphamide 93 Palliative Care 92 Counseling 92 Resistance Training 82 Magnetic Resonance Imaging 81 Cisplatin 79 Saline Solution 77 Radiofrequency Ablation 77 Radiotherapy, Intensity-Modulated 72 Specimen Handling 71 Colonoscopy 70 Cognitive Behavioral Therapy 68

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04790708 2021-03-10

FENET-2016

University Hospital of Ferrara

Phase NA Unknown

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡